FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulatory submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

SUPPL AP for CISPLATIN (CISPLATIN)